Paper

Tree Display

AceDB Schema

XML Display

Feedback

Paper Report for: Xu_2020_Front.Pharmacol_11_593982

Reference

Title: Physiologically-Based Pharmacokinetic-Pharmacodynamics Model Characterizing CYP2C19 Polymorphisms to Predict Clopidogrel Pharmacokinetics and Its Anti-Platelet Aggregation Effect Following Oral Administration to Coronary Artery Disease Patients With or Without Diabetes
Xu RJ, Kong WM, An XF, Zou JJ, Liu L, Liu XD
Ref: Front Pharmacol, 11:593982, 2020 : PubMed

        



Related information



Citations formats

Xu RJ, Kong WM, An XF, Zou JJ, Liu L, Liu XD (2020)
Physiologically-Based Pharmacokinetic-Pharmacodynamics Model Characterizing CYP2C19 Polymorphisms to Predict Clopidogrel Pharmacokinetics and Its Anti-Platelet Aggregation Effect Following Oral Administration to Coronary Artery Disease Patients With or Without Diabetes
Front Pharmacol 11: 593982

Xu RJ, Kong WM, An XF, Zou JJ, Liu L, Liu XD (2020)
Front Pharmacol 11: 593982



Send your questions or comments to :
Mail to: Nicolas Lenfant, Thierry Hotelier, Yves Bourne, Pascale Marchot and Arnaud Chatonnet.
Please cite: Lenfant 2013 Nucleic.Acids.Res. or Marchot Chatonnet 2012 Prot.Pept Lett.
For technical information about these pages see:
ESTHER Home Page and ACEDB Home Page
AcePerl Lincoln Stein Home Page
webmaster

Acknowledgements and disclaimer